The SBIR Restart Is Here. A Startup Founder's Playbook for the New Rules.

The first new SBIR solicitations in six months are about to hit the wire. That changes everything — and nothing.

The Small Business Innovation and Economic Security Act, signed into law after the longest lapse in the programs' 43-year history, reauthorizes SBIR and STTR through 2031. DoD and NIH are expected to publish their first post-lapse solicitations in March or April, with NSF, DOE, and NASA following through May. Smaller agencies — USDA, EPA, NOAA, DHS — will restart on varying timelines into summer.

But the programs that come back online are not the ones that went dark in September. The reauthorization didn't just restart the machinery. It rebuilt the engine. Proposal caps, $30 million Strategic Breakthrough Awards, mandatory foreign risk screening, and new commercialization pressure create a fundamentally different competitive landscape for the roughly 6,000 small businesses that win awards in a typical year.

If you're running a startup that depends on federal R&D funding, the next 90 days are the most strategically consequential window you'll face before 2031. Here's how to navigate it.

The Compressed Cycle: Six Months of Solicitations in Three

Federal agencies don't lose money quietly. The five-month freeze created a backlog of unissued solicitations, unevaluated topics, and unspent appropriations that agencies are now scrambling to clear before the fiscal year ends on September 30. DoD's topic development teams — Army, Navy, Air Force, Space Force, DARPA, Missile Defense Agency — continued working through the shutdown. They have shelved topic lists ready to publish. NIH maintained its study section infrastructure throughout the lapse and can restart reviews rapidly.

The practical effect is a solicitation compression unlike anything the SBIR ecosystem has experienced. Agencies that normally spread topics across two or three solicitation windows per year will attempt to issue them in a condensed timeframe. For startups, this creates both opportunity and triage pressure.

The opportunity is obvious: more topics, more awards, more chances to get funded. The pressure is less obvious but more consequential: if you try to respond to everything, you'll submit mediocre proposals to topics where your fit is marginal. In a compressed cycle where review panels are processing higher volumes, marginal proposals don't get second looks.

The winning strategy is ruthless prioritization. Identify the three to five topics where your technical capabilities are strongest and your commercialization narrative is most credible. Write those proposals to the highest standard you can achieve. Let the rest go. The companies that spray proposals across 20 topics hoping to hit something will underperform the companies that dominate a handful of competitions where they genuinely belong.

Proposal Caps: The End of the Volume Game

The new law gives each agency's SBIR/STTR program director the authority to set annual limits on how many proposals a single company can submit. The caps take effect in FY2027, but agencies are signaling their approaches now, and the signals matter for how you plan your pipeline.

Each director chooses the structure — per fiscal year, per solicitation, or per topic. An agency like DoD, which releases solicitations with hundreds of individual topics, might set a per-topic limit while maintaining a higher annual ceiling. NIH, which funds investigator-initiated research across 27 institutes, might set per-institute or per-fiscal-year limits that force companies to choose between research areas.

Waivers exist but are narrow: only for "time-sensitive and urgent" topics, requiring written justification and senior approval, capped at 5 percent of topics annually. The waiver structure makes clear that this is not a soft guideline. It is a binding constraint.

For startups that have historically submitted 10 or 15 proposals per year, the caps are unlikely to bite. For the multi-award winners that submit 30, 50, or 100+ proposals annually and win outsized shares of the total pool — the firms that critics have called "SBIR mills" — the landscape narrows considerably.

The strategic implication for smaller startups is positive. If incumbents are capped, every topic they don't submit to is a topic where competition decreases. First-time applicants who have been deterred by the perception that SBIR is dominated by repeat winners should reconsider. The playing field is being leveled, and the first post-cap solicitation cycle will be the most open competitive environment the programs have offered in years.

Strategic Breakthrough Awards: $30 Million Changes the Math

The creation of Strategic Breakthrough Awards — post-Phase II funding up to $30 million over 48 months — is the most structurally significant change to SBIR since the STTR program was established in 1992.

The traditional SBIR funding ladder has a well-documented structural flaw. Phase I ($150K-$275K) proves a concept. Phase II ($750K-$1.75M) develops it. Then what? The technology works but isn't ready for production. Private investors want to see government validation beyond Phase II but before committing growth capital. Government procurement officers want to see a production-ready product before issuing Phase III contracts. The company is stuck in the middle — the valley of death that has killed more SBIR-funded innovations than any technical failure.

Strategic Breakthrough Awards are designed to fill that gap. But the eligibility requirements are deliberately exclusive. You need at least one prior Phase II award. You need 100 percent matching funds from qualifying sources — private investment, non-SBIR government contracts, or revenue. For defense-related awards, at least 20 percent of the match must come from non-SBIR DoD sources.

The total pool is capped at 0.50 percent of each agency's extramural R&D budget. For DoD, that translates to roughly $100-150 million annually. For NIH, $80-100 million. These are not small numbers, but spread across $30 million awards, they fund a select cohort — perhaps five to ten companies per major agency per year.

What this means for your startup depends entirely on where you sit:

Pre-Phase I companies should treat the Strategic Breakthrough pathway as a long-term planning horizon. The awards won't be relevant for you for three to five years, but knowing they exist should inform how you structure your Phase I and Phase II proposals. Build the commercialization narrative from day one. Document customer discovery, market validation, and investor interest even during the proof-of-concept phase. The companies that win Strategic Breakthroughs will be the ones whose Phase I and Phase II records tell a coherent commercialization story.

Companies with active Phase II awards should start modeling the match requirement immediately. If you have raised venture capital, secured non-SBIR government contracts, or generated product revenue, you may already qualify. Identify the gap between your current matching capacity and the 100 percent threshold. If you need additional private investment or contract revenue to qualify, start those conversations now — before the first Strategic Breakthrough solicitations publish.

Companies with Phase III contracts already have the commercial relationships that the program requires. For these firms, Strategic Breakthrough Awards represent a way to fund the next-generation R&D that Phase III production contracts don't cover. The question is whether you can articulate a technology development plan ambitious enough to justify a $30 million award while demonstrating the commercial traction to satisfy the matching requirement.

Foreign Risk Screening: What It Actually Means

Every SBIR and STTR application will now undergo a mandatory due diligence review covering cybersecurity practices, patent portfolios, employee backgrounds, and financial ties to foreign countries of concern. The screening checks applicants against federal watchlists.

The provision is not as alarming as it sounds for most startups, but it requires preparation. The screening will add processing time to every application. Companies that cannot quickly document clean backgrounds will face delays that could push them past review cycles.

The practical steps are straightforward. Audit your cap table — know every investor and their nationality. Review your patent assignments for any foreign co-inventors or assignees. Check your employee roster for affiliations with foreign government-funded institutions. Examine your subcontractor agreements for foreign connections.

The bill includes a safeguard that matters: when an agency denies an application based on a security-risk determination, it must provide written notice explaining the basis. Denials are not permanent bars. This notice-and-appeal structure protects legitimate companies with incidental foreign connections — a founder who studied abroad, a company with European angel investors, a team that includes researchers who trained at foreign universities.

The key is proactive documentation. Don't wait for the screening process to surface questions you could have answered in advance. Prepare a one-page foreign connections summary for your internal files, and be ready to include relevant context in your proposal if any flags exist.

The 90-Day Window

The companies that win in the post-reauthorization landscape will share three characteristics: they prepared during the freeze, they understand the new rules, and they execute in the compressed cycle rather than waiting for "normal" to return.

Normal is not returning. The five-year authorization eliminates the threat of another lapse until 2031, but the structural changes — caps, Strategic Breakthroughs, foreign screening — are permanent features of a modernized program. The startups that adapt fastest will capture a disproportionate share of the first post-lapse awards.

Here's what to do this week. Finalize your technical narratives and update your team biosketches. Identify your top three to five agency-topic matches. Audit your foreign connections documentation. Model your Strategic Breakthrough eligibility if you hold Phase II awards. And watch your target agencies' SBIR offices for the first solicitation announcements — because when they drop, the companies that are already ready will be the ones that submit first and strongest.

Granted tracks SBIR and STTR solicitations across all 11 participating agencies, helping startups identify the right opportunities the moment they publish.